In the case of VB12, one NIH prospective study of consecutive ZES cases [27] reported results after a mean of 4.5 years of PPI treatment or up to 10 years of histamine H2 receptor antagonist treatment in 131 ZES patients. This evidence concerns the gene HRH2 and Zollinger-Ellison syndrome.